Zoledronic Acid Attenuates Early Bone Loss at Forearm in Patients with Acute Spinal Cord Injury.

Published in: Indian journal of orthopaedics (2020)

Single dose of 5mg intravenous Zoledronic acid is an effective treatment in preventing bone loss at the forearm for 12 months following acute spinal cord injury.

Keyphrases

bone loss
spinal cord injury
spinal cord
neuropathic pain
liver failure
respiratory failure
high dose
drug induced
combination therapy
hepatitis b virus
replacement therapy
extracorporeal membrane oxygenation
mechanical ventilation
acute respiratory distress syndrome